'I'm cautiously optimistic': Imperial's Robin Shattock on his coronavirus vaccine
Team is using new approach that could be cheap and scalable and become the norm within five yearsProf Robin Shattock would have liked slightly longer to develop the revolutionary approach to vaccines that he is pretty sure will not only save lives in the Covid-19 pandemic but become the norm for vaccine development within five years.His team at Imperial College were working on Ebola and Lassa fever vaccines using new technology but had not got as far as human trials when a novel coronavirus started to kill thousands of people in Wuhan, China.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 3, 2020 Category: Science Authors: Sarah Boseley Health editor Tags: Vaccines and immunisation Coronavirus outbreak Medical research Health Science Society Source Type: news
Johnson & Johnson Announces European Commission Approval for Janssen ’s Preventive Ebola Vaccine
Discussions with the U.S. Food and Drug Administration (FDA) have taken place to define the required data set for filing US licensure. About Janssen’s Ebola Vaccine Regimen The Janssen preventive Ebola vaccine regimen, Ad26.ZEBOV and MVA-BN-Filo, utilizes a non-replicating viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors carry the genetic code of several Ebola virus proteins in order to trigger an immune response.Janssen’s vaccine regimen ori...
Source: Johnson and Johnson - July 1, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
How Deforestation Helps Deadly Viruses Jump from Animals to Humans
This article is republished from The Conversation under a Creative Commons license. Read the original article.
The post How Deforestation Helps Deadly Viruses Jump from Animals to Humans appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - June 26, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Environment Global Headlines Health TerraViva United Nations Source Type: news
The U.S. Government's Push For Coronavirus Vaccine 'Warp Speed' Faces Potential Black Hole Of Red Tape And Universe Of Unknowns
Dr. Stephen Thomas, who helped develop vaccine candidates for diseases such as Ebola, Zika and MERS, discusses the challenges involved in accelerating development during a pandemic. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 16, 2020 Category: Pharmaceuticals Authors: Stephen Thomas, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Business /business Policy /policy Editors' Pick editors-pick Decision Maker decision-maker Coronavirus Source Type: news
New Report: 1,200+ Incidents of Violence Against Health Care in 2019
This article was originally published by theSafeguarding Health in Conflict Coalition. (Source: IntraHealth International)
Source: IntraHealth International - June 11, 2020 Category: International Medicine & Public Health Authors: cbishopp Tags: Safeguarding Health in Conflict Coalition Global health security Health Workers Source Type: news
What is lost in the smoke of COVID-19
Devyn Holliday, Research Officer, Economic, Youth & Sustainable Development Directorate
This blog is part of the seminar series on ‘The Economics of COVID-19’.By Devyn HollidayJun 10 2020 (IPS-Partners) When countries shuttered their shops, closed their markets, and cordoned off places of gathering to help ward off the coronavirus, they did so out of immediate concern for the health and wellbeing of their citizens.
However, as these measures endure the virus is no longer the sole threat to the health and wellbeing of citizens. People across the globe are facing mounting threats to their wellbeing compounded b...
Source: IPS Inter Press Service - Health - June 10, 2020 Category: International Medicine & Public Health Authors: Devyn Holliday Tags: Economy & Trade Health Labour Source Type: news
Melinda Gates Lays Out Her Biggest Concern For the Next Phase of the COVID-19 Pandemic
From 2018-2019, the Bill and Melinda Gates Foundation gave more money to the World Health Organization than any entity except the U.S. government.
With President Donald Trump cutting ties to the international health agency in the midst of the COVID-19 pandemic, the Gates Foundation’s work has come into sharper relief than ever. Co-chair Bill Gates announced at the Global Vaccine Summit on June 4 that it will give $1.6 billion over five years to the Vaccine Alliance (GAVI), to help ensure that people around the world have access to vaccines, regardless of income. The Gates Foundation in 1999 pledged $750 million to he...
Source: TIME: Health - June 4, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news
Africa: Ebola, Hydroxychloroquine, COVID-19 – WHO Tackles a World of Health Challenges
[allAfrica] Washington, DC -Almost 50 responders from the World Health Organization (WHO) and its partners arrived today in Mbandaka in the Democratic Republic of Congo (DRC), along with 3600 doses of Ebola vaccine and 2000 cartridges for lab testing, WHO Director-General Dr. Tedros Adhanom Ghebreyesus told media in an online briefing. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 3, 2020 Category: African Health Source Type: news
COVID 19 – Conspiracy or Apocalypse? – Part I
By Daud Khan and Leila Yasmine KhanAMSTERDAM/ROME, Jun 1 2020 (IPS) As the COVID-19 virus spread rapidly around the globe, so did various theories about what caused the pandemic. According to the standard scientific theory, the virus probably originated in bats and then crossed over to humans, probably via another intermediate host. It then spread rapidly across the globe, piggybacking on the international travel network.
While the mainstream scientific theory sufficed for some, a large number of people saw the pandemic as the work of cold-hearted military or industrial strategists. An equally large number of people saw it...
Source: IPS Inter Press Service - Health - June 1, 2020 Category: International Medicine & Public Health Authors: Daud Khan and Leila Yasmine Khan Tags: Global Headlines Health Source Type: news
Johnson & Johnson Receives Positive CHMP Opinion for Janssen ’s Investigational Preventive Ebola Vaccine Regimen
Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order to trigger an immun...
Source: Johnson and Johnson - May 29, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
European agency panel recommends approval of J & J's Ebola vaccine
A panel of the European health regulator on Friday recommended approving Johnson& Johnson's two-dose experimental vaccine for Ebola in the European Union. (Source: Reuters: Health)
Source: Reuters: Health - May 29, 2020 Category: Consumer Health News Tags: healthNews Source Type: news
How Remdesivir Works to Fight COVID-19 Inside the Body
On May 1, the U.S Food and Drug Administration issued an emergency-use authorization of remdesivir, an experimental anti-viral drug. With this clearance, doctors in the U.S. are now allowed to use the drug to treat patients with severe cases of COVID-19.
Remdesivir isn’t new. It was initially developed to treat Ebola and was also tested in the lab against SARS and MERS—two other coronaviruses that infect humans much like the virus that causes COVID-19. It never made it to the approval stage for those uses, but over the last four months, scientists desperate for options to help mitigate the coronavirus pandemic ...
Source: TIME: Science - May 21, 2020 Category: Science Authors: Emily Barone and Lon Tweeten Tags: Uncategorized COVID-19 Source Type: news
How Remdesivir Works to Fight COVID-19 Inside the Body
On May 1, the U.S Food and Drug Administration issued an emergency-use authorization of remdesivir, an experimental anti-viral drug. With this clearance, doctors in the U.S. are now allowed to use the drug to treat patients with severe cases of COVID-19.
Remdesivir isn’t new. It was initially developed to treat Ebola and was also tested in the lab against SARS and MERS—two other coronaviruses that infect humans much like the virus that causes COVID-19. It never made it to the approval stage for those uses, but over the last four months, scientists desperate for options to help mitigate the coronavirus pandemic ...
Source: TIME: Health - May 21, 2020 Category: Consumer Health News Authors: Emily Barone and Lon Tweeten Tags: Uncategorized COVID-19 Source Type: news
The Scientist Behind Some of the World ’s Best Coronavirus Images
From her laboratory in the far western reaches of Montana, Elizabeth Fischer is trying to help people see what they’re up against in COVID-19.
Over the past three decades, Fischer, 58, and her team at the Rocky Mountain Laboratories, part of the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases, have captured and created some of the more dramatic images of the world’s most dangerous pathogens.
“I like to get images out there to try to convey that this is an entity, to try to demystify it, so this is something more tangible for people,” says Fischer, on...
Source: TIME: Health - May 20, 2020 Category: Consumer Health News Authors: Markian Hawryluk / Kaiser Health News Tags: Uncategorized COVID-19 Source Type: news
The Scientist Behind Some of the World ’s Best Coronavirus Images
From her laboratory in the far western reaches of Montana, Elizabeth Fischer is trying to help people see what they’re up against in COVID-19.
Over the past three decades, Fischer, 58, and her team at the Rocky Mountain Laboratories, part of the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases, have captured and created some of the more dramatic images of the world’s most dangerous pathogens.
“I like to get images out there to try to convey that this is an entity, to try to demystify it, so this is something more tangible for people,” says Fischer, on...
Source: TIME: Science - May 20, 2020 Category: Science Authors: Markian Hawryluk / Kaiser Health News Tags: Uncategorized COVID-19 Source Type: news
